文献速递自身免疫性与大疱性皮肤病药疹与重症皮肤不良反应

老年人常用药物与疫苗与大疱性类天疱疮的关联:病例对照研究

Association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case-control study.
PubMed 文献 · Br J Dermatol · 2025-01-01

该研究基于英国临床实践研究数据链1998–2021年的电子初级保健记录,开展嵌套病例对照研究,匹配最多5名对照,采用多变量条件logistic回归调整多种用药。结果显示抗生素与BP风险关联最强(OR 4.60,95%CI 4.40–4.80),调整前驱偏倚后降至2.08(95%CI 1.99–2.17);青霉素酶耐药青霉素、格列汀类和第二代抗精神病药亦呈较强关联。作者建议临床医生在处方这些药物时警惕BP风险,但不建议为避免BP而停用相关药物。

要点

  • 抗生素与BP风险关联最强,调整前驱偏倚后OR为2.08。
  • 青霉素酶耐药青霉素、格列汀类和第二代抗精神病药与BP风险升高相关。
  • 不建议为避免BP而避免使用相关药物,因多数用药者不会发生BP。

核心结论

  • 抗生素、格列汀类和第二代抗精神病药与老年人BP风险升高相关,但调整前驱偏倚后抗生素的关联减弱。
  • 因BP患病率低,不建议为避免BP而避免使用相关药物/疫苗,但应警惕皮肤反应并早期识别BP。

研究设计与样本

  • 基于英国临床实践研究数据链1998–2021年电子初级保健记录的人群嵌套病例对照研究。
  • BP患者与最多5名对照匹配,暴露为老年人常用药物/疫苗,采用多变量条件logistic回归调整多种用药。
  • 针对抗生素进行敏感性分析以考虑前驱偏倚(药物可能因BP早期类似皮肤感染症状而被处方)。

主要发现

  • 抗生素与BP风险关联最高(OR 4.60,95%CI 4.40–4.80),调整前驱偏倚后OR降至2.08(95%CI 1.99–2.17)。
  • 调整前驱偏倚后,青霉素类OR 3.44(95%CI 3.29–3.60;敏感性分析OR 1.74,95%CI 1.66–1.84)。
  • 调整前驱偏倚后,青霉素酶耐药青霉素OR 7.56(95%CI 7.15–8.00;敏感性分析OR 2.64,95%CI 2.45–2.85)。
  • 格列汀类OR 2.77(95%CI 2.37–3.23),第二代抗精神病药OR 2.58(95%CI 2.20–3.03)。

临床怎么用

  • 临床医生应了解老年人BP风险,尤其在处方青霉素酶耐药青霉素、格列汀类和第二代抗精神病药时。
  • 用药后应关注皮肤反应,以便早期识别、怀疑BP并及时转诊皮肤科诊断。
  • 早期诊断可能减少激进治疗并改善患者健康状态。

局限性

  • BP患病率低,研究结果不支持为避免BP而避免使用相关药物/疫苗。
  • 未来研究需考虑抗生素使用的时间最近性、剂量和治疗持续时间对BP风险的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bullous pemphigoid (BP) is an autoimmune skin disease that mainly affects older people. Based on case series and small hospital-based studies, a number of drugs have been associated with BP. More reliable and precise estimates of associations between a broad selection of drugs/vaccines and BP will enable greater awareness of any potential increased risk of BP following the administration of certain medicines and help identify clinical, histological and genomic characteristics of drug-induced BP for different culprit drugs. Greater awareness could lead to earlier recognition or suspicion of BP and referral to a dermatologist for diagnosis. Earlier diagnosis may lead to less aggressive treatment and improved wellbeing. OBJECTIVES: To determine the association between drugs/vaccines commonly prescribed to older people and the risk of developing BP. METHODS: We conducted a population-based nested case-control study between 1998 and 2021 using electronic primary care records from the Clinical Practice Research Datalink. We matched patients with BP with up to five controls. Exposures were drugs/vaccines commonly prescribed to older people. We used multivariable conditional logistic regression adjusting for multiple drug use. For antibiotics, in a sensitivity analysis, we considered that drugs may be prescribed for undiagnosed symptoms of BP that resemble skin infection (protopathic bias). RESULTS: Antibiotics were associated with the highest risk of BP [odds ratio (OR) 4.60, 95% confidence interval (CI) 4.40-4.80]. However, after adjusting for protopathic bias, the OR decreased to 2.08 (95% CI 1.99-2.17). Also, after adjusting for protopathic bias, of all the antibiotic classes and subclasses, penicillins [OR 3.44, 95% CI 3.29-3.60 (sensitivity analysis OR 1.74, 95% CI 1.66-1.84)] and penicillinase-resistant penicillins [OR 7.56, 95% CI 7.15-8.00 (sensitivity analysis OR 2.64, 95% CI 2.45-2.85)] had the strongest associations with BP risk. Other drugs strongly associated with increased risk were gliptins (OR 2.77, 95% CI 2.37-3.23) and second-generation antipsychotics (OR 2.58, 95% CI 2.20-3.03). CONCLUSIONS: Healthcare professionals need to be aware of BP risk in older people, particularly when prescribing penicillinase-resistant penicillins, gliptins and second-generation antipsychotic drugs, to recognize and manage BP early. Owing to the low disease prevalence, we do not suggest avoiding certain drugs/vaccines to prevent BP. Further research should consider recency, dosage and duration of antibiotic treatments. Bullous pemphigoid (or ‘BP’ for short) is a serious and rare skin condition. It mainly affects older people. About 8 in every 100,000 people in the UK will develop BP for the first time each year. The initial symptoms are often very itchy skin and a red rash that can develop into painful blisters and open sores. Although we do not know which factors trigger BP, it has been suggested that certain medications may cause it. However, these findings have mainly been from small studies and specialist hospitals. It is important to provide reliable estimates of the risk of BP following medication use from a population that is representative of the whole of the UK. This study was carried out in the UK, and may help GPs to suspect BP early on. This may allow them to refer patients to a dermatologist who will diagnose and treat symptoms. We used routinely collected data from more than 2,000 GP surgeries in the UK to find out the risk of BP. We also took into consideration that older people can take many medications at the same time. We found that some antibiotic, anti-diabetic and anti-psychotic drugs are associated with an increased risk of BP. Our findings highlight how important it is to look for skin reactions after using certain medications, and to recognize and manage BP quickly. We advise against avoiding these medications, as most people taking them do not develop BP. Future research could explore how the dosage, treatment duration and recency of antibiotics affect the risk of BP.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Swiderski M, Vinogradova Y, Knaggs RD, et al. Association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case-control study. Br J Dermatol. 2025. PMID: 39467333. doi:10.1093/bjd/ljae416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。